Similarly, mutation of mitochondrial prolyl-tRNA synthetase 2 (PARS2), which is associated with neurological diseases such as Alpers syndrome and some infantile-onset neurodegenerative disorders, is also accompanied by delayed myelinating phenotypes [35,36]. Here, PARS2 is linked to Alpers syndrome.